(SLGN) Silgan Holdings - Ratings and Ratios
Dispensing Closures, Metal Cans, Custom Plastic Containers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.90% |
| Yield on Cost 5y | 2.32% |
| Yield CAGR 5y | 9.33% |
| Payout Consistency | 55.2% |
| Payout Ratio | 24.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 31.6% |
| Value at Risk 5%th | 46.8% |
| Relative Tail Risk | -9.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.55 |
| Alpha | -28.49 |
| CAGR/Max DD | -0.17 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.545 |
| Beta | 0.638 |
| Beta Downside | 0.558 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.70% |
| Mean DD | 13.53% |
| Median DD | 13.62% |
Description: SLGN Silgan Holdings January 08, 2026
Silgan Holdings Inc. (NYSE: SLGN) manufactures rigid packaging solutions for consumer-goods manufacturers in the U.S. and abroad, operating through three segments: Dispensing & Specialty Closures, Metal Containers, and Custom Containers.
The Dispensing & Specialty Closures segment supplies proprietary metal and plastic closures, capping equipment, and fragrance-detection systems to the food, beverage, personal-care, and home-care markets. The Metal Containers business produces steel and aluminum cans for pet food, soups, proteins, and other shelf-stable foods, while the Custom Containers segment offers high-density polyethylene (HDPE) and PET trays, thermoformed bowls, and specialty plastic fitments for both food and household products. Sales are driven primarily by a direct sales force, supplemented by distributors and an online catalog.
In FY 2023 Silgan reported revenue of roughly $2.5 billion with an adjusted EBITDA margin near 10%, reflecting modest pricing power but sensitivity to raw-material costs (steel, aluminum, resin). Key economic drivers include food-price inflation, which boosts demand for durable metal cans, and the continued shift toward e-commerce packaging that favors high-volume, low-cost closures. The company’s exposure to commodity price volatility and its ability to pass through cost increases remain central to earnings outlook.
For a deeper quantitative view of SLGN’s valuation metrics, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (339.6m TTM) > 0 and > 6% of Revenue (6% = 413.7m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -1.46pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.59% (prev 3.70%; Δ 5.90pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 934.1m > Net Income 339.6m (YES >=105%, WARN >=100%) |
| Net Debt (4.56b) to EBITDA (661.9m) ratio: 6.89 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (105.7m) change vs 12m ago -1.37% (target <= -2.0% for YES) |
| Gross Margin 16.88% (prev 17.14%; Δ -0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 79.97% (prev 74.65%; Δ 5.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.25 (EBITDA TTM 661.9m / Interest Expense TTM 187.4m) >= 6 (WARN >= 3) |
Altman Z'' 2.55
| (A) 0.07 = (Total Current Assets 3.11b - Total Current Liabilities 2.45b) / Total Assets 9.50b |
| (B) 0.38 = Retained Earnings (Balance) 3.61b / Total Assets 9.50b |
| (C) 0.05 = EBIT TTM 422.4m / Avg Total Assets 8.62b |
| (D) 0.50 = Book Value of Equity 3.61b / Total Liabilities 7.23b |
| Total Rating: 2.55 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.54
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.40% |
| 3. FCF Margin 9.00% |
| 4. Debt/Equity 1.92 |
| 5. Debt/Ebitda 6.89 |
| 6. ROIC - WACC (= 0.04)% |
| 7. RoE 15.86% |
| 8. Rev. Trend 29.68% |
| 9. EPS Trend -8.09% |
What is the price of SLGN shares?
Over the past week, the price has changed by +2.01%, over one month by +9.61%, over three months by -2.68% and over the past year by -16.17%.
Is SLGN a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the SLGN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.8 | 18.4% |
| Analysts Target Price | 49.8 | 18.4% |
| ValueRay Target Price | 40.8 | -3% |
SLGN Fundamental Data Overview January 06, 2026
P/E Forward = 10.582
P/S = 0.6868
P/B = 1.9181
P/EG = 0.8384
Beta = 0.737
Revenue TTM = 6.90b USD
EBIT TTM = 422.4m USD
EBITDA TTM = 661.9m USD
Long Term Debt = 3.81b USD (from longTermDebt, last quarter)
Short Term Debt = 1.13b USD (from shortLongTermDebt, last quarter)
Debt = 4.36b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 4.56b USD (from netDebt column, last quarter)
Enterprise Value = 8.38b USD (4.41b + Debt 4.36b - CCE 389.2m)
Interest Coverage Ratio = 2.25 (Ebit TTM 422.4m / Interest Expense TTM 187.4m)
FCF Yield = 7.40% (FCF TTM 620.3m / Enterprise Value 8.38b)
FCF Margin = 9.00% (FCF TTM 620.3m / Revenue TTM 6.90b)
Net Margin = 4.93% (Net Income TTM 339.6m / Revenue TTM 6.90b)
Gross Margin = 16.88% ((Revenue TTM 6.90b - Cost of Revenue TTM 5.73b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 16.29%)
Tobins Q-Ratio = 0.88 (Enterprise Value 8.38b / Total Assets 9.50b)
Interest Expense / Debt = 1.15% (Interest Expense 50.0m / Debt 4.36b)
Taxrate = 24.32% (36.2m / 148.7m)
NOPAT = 319.7m (EBIT 422.4m * (1 - 24.32%))
Current Ratio = 1.27 (Total Current Assets 3.11b / Total Current Liabilities 2.45b)
Debt / Equity = 1.92 (Debt 4.36b / totalStockholderEquity, last quarter 2.27b)
Debt / EBITDA = 6.89 (Net Debt 4.56b / EBITDA 661.9m)
Debt / FCF = 7.35 (Net Debt 4.56b / FCF TTM 620.3m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.94% (Net Income 339.6m / Total Assets 9.50b)
RoE = 15.86% (Net Income TTM 339.6m / Total Stockholder Equity 2.14b)
RoCE = 7.09% (EBIT 422.4m / Capital Employed (Equity 2.14b + L.T.Debt 3.81b))
RoIC = 4.68% (NOPAT 319.7m / Invested Capital 6.83b)
WACC = 4.64% (E(4.41b)/V(8.77b) * Re(8.36%) + D(4.36b)/V(8.77b) * Rd(1.15%) * (1-Tc(0.24)))
Discount Rate = 8.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.58%
[DCF Debug] Terminal Value 87.00% ; FCFF base≈619.9m ; Y1≈664.7m ; Y5≈810.7m
Fair Price DCF = 183.1 (EV 23.91b - Net Debt 4.56b = Equity 19.35b / Shares 105.7m; r=6.0% [WACC]; 5y FCF grow 8.09% → 3.0% )
EPS Correlation: -8.09 | EPS CAGR: 8.16% | SUE: -0.36 | # QB: 0
Revenue Correlation: 29.68 | Revenue CAGR: 9.30% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.79 | Chg30d=-0.011 | Revisions Net=-1 | Analysts=8
EPS next Year (2026-12-31): EPS=3.86 | Chg30d=-0.036 | Revisions Net=-1 | Growth EPS=+4.5% | Growth Revenue=+2.2%
Additional Sources for SLGN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle